2. Academic Validation
  3. Pseudolaric acid B activates autophagy in MCF-7 human breast cancer cells to prevent cell death

Pseudolaric acid B activates autophagy in MCF-7 human breast cancer cells to prevent cell death

  • Oncol Lett. 2016 Mar;11(3):1731-1737. doi: 10.3892/ol.2016.4103.
Jinghua Yu 1,  Chunhai Chen 2,  Tianyang Xu 3,  Minghui Yan 4,  Bianbian Xue 5,  Ying Wang 5,  Chunyu Liu 2,  Ting Zhong 6,  Zengyan Wang 7,  Xianying Meng 8,  Donghua Hu 6,  Xiaofang Yu 9
Affiliations

Affiliations

  • 1 Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • 2 Department of Acupunture, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130000, P.R. China.
  • 3 Department of Drug Analysis and Analytical Chemistry, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China.
  • 4 Department of Biomedical Engineering, College of Pharmacy, Jilin University, Changchun, Jilin 130000, P.R. China.
  • 5 Department of Gastroenterology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • 6 Department of Medicinal Chemistry, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China.
  • 7 Department of Internal Medicine, The First Hospital of Jilin University, Changchun, Jilin 130000, P.R. China.
  • 8 Department of Thyroid Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • 9 Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
PMID: 26998069 DOI: 10.3892/ol.2016.4103
Abstract

Pseudolaric acid B (PAB) has been demonstrated to exert antitumor effects in MCF-7 human breast Cancer cells. The present study aimed to investigate the mechanism of resistance to PAB-induced cell death. Following incubation with 4 µM of PAB for 3 days, the majority of MCF-7 cells became senescent, while some retained the same morphology as control cells, as assessed using a senescence detection kit. Additionally, 36 h of treatment with 4 µM of PAB increased the positive staining of Autophagy markers, as shown by monodansylcadaverine and acridine orange staining. Western blot analysis indicated that this treatment also increased expression of the autophagy-related proteins Beclin-1 and microtubule-associated protein 1 LIGHT chain 3. Furthermore, treatment with PAB and the Autophagy Inhibitor 3-methyl adenine significantly decreased the ratio of Autophagy, as assessed by flow cytometric analysis of monodansylcadaverine staining density (P<0.001), and increased the ratio of cell death, as assessed by MTT analysis (P<0.001). This indicated that Autophagy promotes cell survival as a resistance mechanism to PAB treatment. Additionally, the present study demonstrated that PAB treatment did not affect the mitochondrial membrane potential, which may be related to Autophagy. Increased Bcl-2 expression may explain why PAB did not affect the mitochondrial membrane potential. A Bcl-2 binding test demonstrated that PAB treatment inhibits the binding of Bcl-2 and Beclin-1, which may free Beclin-1 to participate in Autophagy. Therefore, the present study demonstrated that Autophagy may be activated by PAB treatment in human breast Cancer MCF-7 cells, contributing to resistance to cell death.

Keywords

MCF-7 human breast cancer cells; autophagy; pseudolaric acid B.

Figures
Products